🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Ray Dalio’s AZN Holdings & Trades

First Buy
Q2 2021
Duration Held
20 Quarters
Largest Add
Q4 2024
+234,176 Shares
Current Position
8,188 Shares
$1.32 M Value

Ray Dalio's AZN Position Overview

Ray Dalio (via Bridgewater Associates, Lp) currently holds 8,188 shares of AstraZeneca PLC (AZN) worth $1.32 M, representing 0.01% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 20 quarters.

Based on 13F filings, Ray Dalio has maintained a strategic position in AZN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 234,176 shares. Largest reduction occurred in Q4 2025, reducing 231,430 shares.

Analysis based on 13F filings available since 2013 Q2

Ray Dalio's AstraZeneca PLC (AZN) Holding Value Over Time

Track share changes against reported price movement

Quarterly AstraZeneca PLC (AZN) Trades by Ray Dalio

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +8,188 New Buy 8,188 $161.47
Q4 2025 -231,430 Sold Out 0 $0.00
Q3 2025 -79,022 Reduce 25.45% 231,430 $153.44
Q2 2025 -35,098 Reduce 10.16% 310,452 $139.76
Q1 2025 +8,820 Add 2.62% 345,550 $147.00
Q4 2024 +234,176 Add 228.34% 336,730 $131.04
Q3 2024 -2,034 Reduce 1.94% 102,554 $155.82
Q2 2024 +54,957 Add 110.73% 104,588 $155.98
Q1 2024 -30,394 Reduce 37.98% 49,631 $135.50
Q4 2023 +23,121 Add 40.63% 80,025 $134.70
Q3 2023 +2,024 Add 3.69% 56,904 $135.44
Q2 2023 +6,074 Add 12.45% 54,880 $143.14
Q1 2023 +3,997 Add 8.92% 48,806 $138.82
Q4 2022 +4,913 Add 12.31% 44,809 $135.60
Q3 2022 +4,395 Add 12.38% 39,896 $109.69
Q2 2022 -2,792 Reduce 7.29% 35,501 $132.14
Q1 2022 +1,847 Add 5.07% 38,293 $132.69
Q4 2021 -15,670 Reduce 30.07% 36,446 $116.50
Q3 2021 +6,448 Add 14.12% 52,116 $120.12
Q2 2021 +45,668 New Buy 45,668 $119.80

Ray Dalio's AstraZeneca PLC Investment FAQs

Ray Dalio first purchased AstraZeneca PLC (AZN) in Q2 2021, acquiring 45,668 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ray Dalio has held AstraZeneca PLC (AZN) for 20 quarters since Q2 2021.

Ray Dalio's largest addition to AstraZeneca PLC (AZN) was in Q4 2024, adding 336,730 shares worth $44.13 M.

According to the latest 13F filing for Q3 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 8,188 shares of AstraZeneca PLC (AZN), valued at approximately $1.32 M.

As of the Q3 2026 filing, AstraZeneca PLC (AZN) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.

Ray Dalio's peak holding in AstraZeneca PLC (AZN) was 345,550 shares, as reported at the end of Q1 2025.